Pharmacology & ToxicologybioRxiv
An in silico exploration of combining Interleukin-12 with Oxaliplatin to treat liver-metastatic colorectal cancer
Q. Wang, Z. Wang, Y. Wu, D. Klinke
This study uses a computational model to explore optimal dosing and timing of IL-12 and Oxaliplatin combination therapy for liver-metastatic colorectal cancer in mice.
DOI 10.1186/s12885-019-6500-9